Clinical trials
Myelodysplastic Syndromes trials in France with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Groupe Francophone des Myelodysplasies | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Institut Paoli-Calmettes | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Grenoble | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 24 |
| Leukemia, Myeloid, Acute | 7 |
| Anemia | 3 |
| Leukemia | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Leukemia, Myeloid | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia, Refractory | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.